Biologics
Protuoso Biosciences Launches with $9.5M to Pioneer AI-Driven “Hub-and-Spoke” Biologics Development
2026-05-27
EirGenix Strengthens U.S. East Coast Presence, Leveraging DCAT Week and TCA Multi-City Events to Expand Global CDMO Opportunities
2026-03-25
[Illustrations] 2026 Policy and Geopolitics as Catalysts: IRA Pricing Mechanics and BIOSECURE’s Supply Chain Decoupling
2026-02-09
Experts Weigh In on AI’s Role, Challenges, and Future in Drug Discovery at the 2025 Taiwan Biotech Forum
2025-06-16
From Labs to Breakthroughs: HanchorBio Aims High in the Immuno-Oncology Market with HCB101
2025-02-17
Key Trends in the Pharmaceutical Pipeline for 2024 — Part I: Transformative R&D Growth Driven by Breakthroughs in Oncology, Neurological, and Metabolic Therapies
2024-10-18
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
LATEST
Syndax Pharmaceuticals CMO Nick Botwood Outlines Leadership Standards for R&D Organizations
2026-08-13
Regeneron Oncology Marketing Lead Sarah Ghosh Details Strategy for Adapting Global Pharmaceutical Narratives
2026-08-13
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




